Paul D. Drew - Publications

Affiliations: 
University of Arkansas for Medical Sciences, United States 
Area:
Neuroscience Biology

67 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Niedzwiedz-Massey VM, Douglas JC, Rafferty T, Wight PA, Kane CJM, Drew PD. Ethanol modulation of hippocampal neuroinflammation, myelination, and neurodevelopment in a postnatal mouse model of fetal alcohol spectrum disorders. Neurotoxicology and Teratology. 87: 107015. PMID 34256161 DOI: 10.1016/j.ntt.2021.107015  0.01
2021 Pinson MR, Holloway KN, Douglas JC, Kane CJM, Miranda RC, Drew PD. Divergent and overlapping hippocampal and cerebellar transcriptome responses following developmental ethanol exposure during the secondary neurogenic period. Alcoholism, Clinical and Experimental Research. PMID 34060105 DOI: 10.1111/acer.14633  0.01
2021 Lowery RL, Cealie MY, Lamantia CE, Mendes MS, Drew PD, Majewska AK. Microglia and astrocytes show limited, acute alterations in morphology and protein expression following a single developmental alcohol exposure. Journal of Neuroscience Research. PMID 33606320 DOI: 10.1002/jnr.24808  0.01
2021 Kane CJM, Douglas JC, Rafferty T, Johnson JW, Niedzwiedz-Massey VM, Phelan KD, Majewska AK, Drew PD. Ethanol modulation of cerebellar neuroinflammation in a postnatal mouse model of fetal alcohol spectrum disorders. Journal of Neuroscience Research. PMID 33533128 DOI: 10.1002/jnr.24797  0.01
2020 Kane CJM, Drew PD. Neuroinflammatory contribution of microglia and astrocytes in fetal alcohol spectrum disorders. Journal of Neuroscience Research. PMID 32959429 DOI: 10.1002/Jnr.24735  0.01
2017 Chen J, Martindale JL, Cramer C, Gorospe M, Atasoy U, Drew PD, Yu S. The RNA-binding protein HuR contributes to neuroinflammation by promoting C-C chemokine receptor 6 (CCR6) expression on Th17 cells. The Journal of Biological Chemistry. PMID 28684423 DOI: 10.1074/Jbc.M117.782771  0.01
2017 Cippitelli A, Domi E, Ubaldi M, Douglas JC, Li HW, Demopulos G, Gaitanaris G, Roberto M, Drew PD, Kane CJ, Ciccocioppo R. Protection against alcohol-induced neuronal and cognitive damage by the PPARγ receptor agonist pioglitazone. Brain, Behavior, and Immunity. PMID 28167117 DOI: 10.1016/J.Bbi.2017.02.001  0.01
2017 Drew PD, Douglas JC, Johnson JW, Phelan KD, Kane CJM. PPAR-γ agonists suppress neuroinflammation in a FASD animal model Alcohol. 59: 73. DOI: 10.1016/J.Alcohol.2016.10.024  0.01
2016 Drew PD, Kane CJ. Peroxisome Proliferator-Activated Receptor-γ Agonists: Potential Therapeutics for Neuropathology Associated with Fetal Alcohol Spectrum Disorders. Journal of Clinical & Cellular Immunology. 7. PMID 28203487 DOI: 10.4172/2155-9899.1000469  0.01
2016 Kane CJ, Drew PD. Inflammatory responses to alcohol in the CNS: nuclear receptors as potential therapeutics for alcohol-induced neuropathologies. Journal of Leukocyte Biology. PMID 27462100 DOI: 10.1189/Jlb.3Mr0416-171R  0.01
2015 Odle AK, Drew PD, Childs GV. Giant mice reveal new roles for GH in regulating the adipose immune microenvironment. Endocrinology. 156: 1613-5. PMID 25886070 DOI: 10.1210/En.2015-1205  0.01
2015 Drew PD, Johnson JW, Douglas JC, Phelan KD, Kane CJ. Pioglitazone blocks ethanol induction of microglial activation and immune responses in the hippocampus, cerebellum, and cerebral cortex in a mouse model of fetal alcohol spectrum disorders. Alcoholism, Clinical and Experimental Research. 39: 445-54. PMID 25703036 DOI: 10.1111/Acer.12639  1
2014 Drew PD, Kane CJ. Fetal alcohol spectrum disorders and neuroimmune changes. International Review of Neurobiology. 118: 41-80. PMID 25175861 DOI: 10.1016/B978-0-12-801284-0.00003-8  0.01
2014 Xie L, Chen J, McMickle A, Awar N, Nady S, Sredni B, Drew PD, Yu S. The immunomodulator AS101 suppresses production of inflammatory cytokines and ameliorates the pathogenesis of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 273: 31-41. PMID 24975323 DOI: 10.1016/J.Jneuroim.2014.05.015  0.01
2014 Kane CJ, Phelan KD, Douglas JC, Wagoner G, Johnson JW, Xu J, Phelan PS, Drew PD. Effects of ethanol on immune response in the brain: region-specific changes in adolescent versus adult mice. Alcoholism, Clinical and Experimental Research. 38: 384-91. PMID 24033454 DOI: 10.1111/Acer.12244  1
2013 Kane CJ, Phelan KD, Douglas JC, Wagoner G, Johnson JW, Xu J, Drew PD. Effects of ethanol on immune response in the brain: region-specific changes in aged mice. Journal of Neuroinflammation. 10: 66. PMID 23701841 DOI: 10.1186/1742-2094-10-66  1
2013 Xu J, Wagoner G, Douglas JC, Drew PD. β-Lapachone ameliorization of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 254: 46-54. PMID 23010281 DOI: 10.1016/J.Jneuroim.2012.09.004  0.01
2012 Wight RD, Tull CA, Deel MW, Stroope BL, Eubanks AG, Chavis JA, Drew PD, Hensley LL. Resveratrol effects on astrocyte function: relevance to neurodegenerative diseases. Biochemical and Biophysical Research Communications. 426: 112-5. PMID 22917537 DOI: 10.1016/J.Bbrc.2012.08.045  0.01
2012 Burns SA, Lee Archer R, Chavis JA, Tull CA, Hensley LL, Drew PD. Mitoxantrone repression of astrocyte activation: relevance to multiple sclerosis. Brain Research. 1473: 236-41. PMID 22884503 DOI: 10.1016/J.Brainres.2012.07.054  1
2012 Kane CJ, Phelan KD, Drew PD. Neuroimmune mechanisms in fetal alcohol spectrum disorder. Developmental Neurobiology. 72: 1302-16. PMID 22623427 DOI: 10.1002/Dneu.22035  0.01
2011 Solt LA, Kumar N, Nuhant P, Wang Y, Lauer JL, Liu J, Istrate MA, Kamenecka TM, Roush WR, Vidovi? D, Schürer SC, Xu J, Wagoner G, Drew PD, Griffin PR, et al. Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand. Nature. 472: 491-4. PMID 21499262 DOI: 10.1038/Nature10075  1
2011 Kane CJ, Phelan KD, Han L, Smith RR, Xie J, Douglas JC, Drew PD. Protection of neurons and microglia against ethanol in a mouse model of fetal alcohol spectrum disorders by peroxisome proliferator-activated receptor-γ agonists. Brain, Behavior, and Immunity. 25: S137-45. PMID 21376806 DOI: 10.1016/J.Bbi.2011.02.016  0.01
2009 Racke MK, Drew PD. Toll-like receptors in multiple sclerosis. Current Topics in Microbiology and Immunology. 336: 155-68. PMID 19688333 DOI: 10.1007/978-3-642-00549-7_9  0.01
2009 Xu J, Wagoner G, Douglas JC, Drew PD. Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity. Journal of Leukocyte Biology. 86: 401-9. PMID 19406833 DOI: 10.1189/Jlb.1008600  0.01
2009 Gocke AR, Hussain RZ, Yang Y, Peng H, Weiner J, Ben LH, Drew PD, Stuve O, Lovett-Racke AE, Racke MK. Transcriptional modulation of the immune response by peroxisome proliferator-activated receptor-{alpha} agonists in autoimmune disease. Journal of Immunology (Baltimore, Md. : 1950). 182: 4479-87. PMID 19299749 DOI: 10.4049/Jimmunol.0713927  0.01
2008 Racke MK, Drew PD. PPARs in Neuroinflammation. Ppar Research. 2008: 638356. PMID 18682822 DOI: 10.1155/2008/638356  0.01
2008 Yang Y, Gocke AR, Lovett-Racke A, Drew PD, Racke MK. PPAR Alpha Regulation of the Immune Response and Autoimmune Encephalomyelitis. Ppar Research. 2008: 546753. PMID 18645614 DOI: 10.1155/2008/546753  0.01
2008 Xu J, Barger SW, Drew PD. The PPAR-gamma Agonist 15-Deoxy-Delta-Prostaglandin J(2) Attenuates Microglial Production of IL-12 Family Cytokines: Potential Relevance to Alzheimer's Disease. Ppar Research. 2008: 349185. PMID 18615183 DOI: 10.1155/2008/349185  1
2008 Drew PD, Xu J, Racke MK. PPAR-gamma: Therapeutic Potential for Multiple Sclerosis. Ppar Research. 2008: 627463. PMID 18604287 DOI: 10.1155/2008/627463  0.01
2008 Kielian T, Syed MM, Liu S, Phulwani NK, Phillips N, Wagoner G, Drew PD, Esen N. The synthetic peroxisome proliferator-activated receptor-gamma agonist ciglitazone attenuates neuroinflammation and accelerates encapsulation in bacterial brain abscesses. Journal of Immunology (Baltimore, Md. : 1950). 180: 5004-16. PMID 18354226 DOI: 10.4049/Jimmunol.180.7.5004  0.01
2007 Xu J, Racke MK, Drew PD. Peroxisome proliferator-activated receptor-alpha agonist fenofibrate regulates IL-12 family cytokine expression in the CNS: relevance to multiple sclerosis. Journal of Neurochemistry. 103: 1801-10. PMID 17727629 DOI: 10.1111/J.1471-4159.2007.04875.X  0.01
2007 Xu J, Drew PD. Peroxisome proliferator-activated receptor-gamma agonists suppress the production of IL-12 family cytokines by activated glia. Journal of Immunology (Baltimore, Md. : 1950). 178: 1904-13. PMID 17237441 DOI: 10.4049/Jimmunol.178.3.1904  0.01
2007 Zhang-Gandhi CX, Drew PD. Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes. Journal of Neuroimmunology. 183: 50-9. PMID 17175031 DOI: 10.1016/J.Jneuroim.2006.11.007  0.01
2006 Xu J, Chavis JA, Racke MK, Drew PD. Peroxisome proliferator-activated receptor-alpha and retinoid X receptor agonists inhibit inflammatory responses of astrocytes. Journal of Neuroimmunology. 176: 95-105. PMID 16764943 DOI: 10.1016/J.Jneuroim.2006.04.019  0.01
2006 Drew PD, Xu J, Storer PD, Chavis JA, Racke MK. Peroxisome proliferator-activated receptor agonist regulation of glial activation: relevance to CNS inflammatory disorders. Neurochemistry International. 49: 183-9. PMID 16753239 DOI: 10.1016/J.Neuint.2006.04.003  0.01
2006 Racke MK, Gocke AR, Muir M, Diab A, Drew PD, Lovett-Racke AE. Nuclear receptors and autoimmune disease: the potential of PPAR agonists to treat multiple sclerosis. The Journal of Nutrition. 136: 700-3. PMID 16484546 DOI: 10.1093/Jn/136.3.700  0.01
2006 Xu J, Drew PD. 9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes. Journal of Neuroimmunology. 171: 135-44. PMID 16303184 DOI: 10.1016/J.Jneuroim.2005.10.004  0.01
2005 Xu J, Storer PD, Chavis JA, Racke MK, Drew PD. Agonists for the peroxisome proliferator-activated receptor-alpha and the retinoid X receptor inhibit inflammatory responses of microglia. Journal of Neuroscience Research. 81: 403-11. PMID 15968640 DOI: 10.1002/Jnr.20518  0.01
2005 Drew PD, Storer PD, Xu J, Chavis JA. Hormone regulation of microglial cell activation: relevance to multiple sclerosis. Brain Research. Brain Research Reviews. 48: 322-7. PMID 15850670 DOI: 10.1016/J.Brainresrev.2004.12.020  0.01
2005 Storer PD, Xu J, Chavis J, Drew PD. Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis. Journal of Neuroimmunology. 161: 113-22. PMID 15748950 DOI: 10.1016/J.Jneuroim.2004.12.015  0.01
2005 Storer PD, Xu J, Chavis JA, Drew PD. Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis. Journal of Neuroscience Research. 80: 66-74. PMID 15723383 DOI: 10.1002/Jnr.20413  0.01
2004 Kielian T, McMahon M, Bearden ED, Baldwin AC, Drew PD, Esen N. S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2). Journal of Neurochemistry. 90: 1163-72. PMID 15312171 DOI: 10.1111/J.1471-4159.2004.02579.X  0.01
2004 Lovett-Racke AE, Hussain RZ, Northrop S, Choy J, Rocchini A, Matthes L, Chavis JA, Diab A, Drew PD, Racke MK. Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease. Journal of Immunology (Baltimore, Md. : 1950). 172: 5790-8. PMID 15100326 DOI: 10.4049/Jimmunol.172.9.5790  0.01
2004 Diab A, Hussain RZ, Lovett-Racke AE, Chavis JA, Drew PD, Racke MK. Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 148: 116-26. PMID 14975592 DOI: 10.1016/J.Jneuroim.2003.11.010  0.01
2003 Drew PD, Chavis JA, Bhatt R. Sex steroid regulation of microglial cell activation: relevance to multiple sclerosis. Annals of the New York Academy of Sciences. 1007: 329-34. PMID 14993065 DOI: 10.1196/Annals.1286.031  0.01
2003 Kielian T, Drew PD. Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation. Journal of Neuroscience Research. 71: 315-25. PMID 12526021 DOI: 10.1002/Jnr.10501  0.01
2002 Diab A, Deng C, Smith JD, Hussain RZ, Phanavanh B, Lovett-Racke AE, Drew PD, Racke MK. Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 168: 2508-15. PMID 11859145 DOI: 10.4049/Jimmunol.168.5.2508  0.01
2001 Drew PD, Moss MT, Pasieka TJ, Grose C, Harris WJ, Porter AJ. Multimeric humanized varicella-zoster virus antibody fragments to gH neutralize virus while monomeric fragments do not. The Journal of General Virology. 82: 1959-63. PMID 11458003 DOI: 10.1099/0022-1317-82-8-1959  1
2001 Drew PD, Chavis JA. The cyclopentone prostaglandin 15-deoxy-Δ12,14 prostaglandin J2 represses nitric oxide, TNF-α, and IL-12 production by microglial cells Journal of Neuroimmunology. 115: 28-35. PMID 11282151 DOI: 10.1016/S0165-5728(01)00267-3  0.01
2000 Barger SW, Chavis JA, Drew PD. Dehydroepiandrosterone inhibits microglial nitric oxide production in a stimulus-specific manner. Journal of Neuroscience Research. 62: 503-9. PMID 11070493 DOI: 10.1002/1097-4547(20001115)62:4<503::Aid-Jnr4>3.0.Co;2-A  1
2000 Drew PD, Chavis JA. Female sex steroids: effects upon microglial cell activation Journal of Neuroimmunology. 111: 77-85. PMID 11063824 DOI: 10.1016/S0165-5728(00)00386-6  0.01
2000 Drew PD, Chavis JA. Inhibition of microglial cell activation by cortisol Brain Research Bulletin. 52: 391-396. PMID 10922518 DOI: 10.1016/S0361-9230(00)00275-6  0.01
1999 Dhillon JK, Drew PD, Porter AJ. Bacterial surface display of an anti-pollutant antibody fragment. Letters in Applied Microbiology. 28: 350-4. PMID 10347888 DOI: 10.1046/J.1365-2672.1999.00552.X  0.01
1998 Chang JY, Chavis JA, Liu L, Drew PD. Cholesterol oxides induce programmed cell death in microglial cells. Biochemical and Biophysical Research Communications. 249: 817-821. PMID 9731219 DOI: 10.1006/Bbrc.1998.9237  0.01
1997 Becker KG, Lee IJ, Nagle JW, Canning RD, Gado AM, Torres R, Polymeropoulos MH, Massa PT, Biddison WE, Drew PD. C2H2-171: a novel human cDNA representing a developmentally regulated POZ domain/zinc finger protein preferentially expressed in brain. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 15: 891-9. PMID 9568537 DOI: 10.1016/S0736-5748(97)00034-8  0.01
1997 Becker KG, Nagle JW, Canning RD, Dehejia AM, Polymeropoulos MH, Gado AM, Biddison WE, Drew PD. Molecular Cloning and Mapping of a Novel Human KRAB Domain-Containing C2H2-Type Zinc Finger to Chromosome 7q36.1 Genomics. 41: 502-504. PMID 9169157 DOI: 10.1006/Geno.1997.4678  0.01
1997 Becker KG, Canning RD, Nagle JW, Dehejia AM, Polymeropoulos MH, Lee IJ, Gado AM, Biddison WE, Drew PD. Molecular cloning and mapping of a novel developmentally regulated human C2H2-type zinc finger. Mammalian Genome. 8: 287-289. PMID 9096115 DOI: 10.1007/S003359900414  0.01
1995 Drew PD, Franzoso G, Becker KG, Bours V, Carlson LM, Siebenlist U, Ozato K. NF kappa B and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expression. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 15: 1037-45. PMID 8746784 DOI: 10.1089/Jir.1995.15.1037  0.01
1995 Drew PD, Franzoso G, Carlson LM, Biddison WE, Siebenlist U, Ozato K. Interferon regulatory factor-2 physically interacts with NF-kappa B in vitro and inhibits NF-kappa B induction of major histocompatibility class I and beta 2-microglobulin gene expression in transfected human neuroblastoma cells. Journal of Neuroimmunology. 63: 157-62. PMID 8550813 DOI: 10.1016/0165-5728(95)00140-9  0.01
1995 Becker KG, Nagle JW, Canning RD, Biddison WE, Ozato K, Drew PD. Rapid isolation and characterization of 118 novel C2H2-type zinc finger cDNAs expressed in human brain Human Molecular Genetics. 4: 685-691. PMID 7633419 DOI: 10.1093/Hmg/4.4.685  0.01
1995 Drew PD, Nagle JW, Canning RD, Ozato K, Biddison WE, Becker KG. Cloning and expression analysis of a human cDNA homologous to Xenopus TFIIIA Gene. 159: 215-218. PMID 7622052 DOI: 10.1016/0378-1119(95)00145-V  0.01
1994 Atwood WJ, Tornatore CS, Traub R, Conant K, Drew PD, Major EO. Stimulation of HIV type 1 gene expression and induction of NF-kappa B (p50/p65)-binding activity in tumor necrosis factor alpha-treated human fetal glial cells. Aids Research and Human Retroviruses. 10: 1207-11. PMID 7848678 DOI: 10.1089/Aid.1994.10.1207  1
1993 Segars JH, Nagata T, Bours V, Medin JA, Franzoso G, Blanco JCG, Drew PD, Becker KG, An J, Tang T, Stephany DA, Neel B, Siebenlist U, Ozato K. Retinoic acid induction of major histocompatibility complex class I genes in NTera-2 embryonal carcinoma cells involves induction of NF-κB (p50-p65) and retinoic acid receptor β-retinoid X receptor β heterodimers Molecular and Cellular Biology. 13: 6157-6169. PMID 8413217 DOI: 10.1128/Mcb.13.10.6157  1
1990 Drew PD, Ades IZ. Induction of cytochrome P-450 RNA by porphyrogenic agents: on the nature of the coordinate induction with delta-aminolevulinate synthase in tissues of the chicken embryo. The International Journal of Biochemistry. 22: 607-10. PMID 1696217 DOI: 10.1016/0020-711X(90)90036-3  0.01
1989 Drew PD, Ades IZ. Regulation of the stability of chicken embryo liver delta-aminolevulinate synthase mRNA by hemin. Biochemical and Biophysical Research Communications. 162: 102-7. PMID 2751643 DOI: 10.1016/0006-291X(89)91968-2  0.01
1987 Ades IZ, Stevens TM, Drew PD. Biogenesis of embryonic chick liver delta-aminolevulinate synthase: regulation of the level of mRNA by hemin. Archives of Biochemistry and Biophysics. 253: 297-304. PMID 3566276 DOI: 10.1016/0003-9861(87)90182-2  0.01
1986 Drew PD, Ades IZ. Regulation of production of embryonic chick liver delta-aminolevulinate synthase: effects of testosterone and of hemin on the mRNA of the enzyme. Biochemical and Biophysical Research Communications. 140: 81-7. PMID 3778461 DOI: 10.1016/0006-291X(86)91060-0  0.01
Show low-probability matches.